US Patent 7998980 Compounds for modulating TRPV3 function
Patent 7998980 was granted and assigned to Hydra Biosciences on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+128 characters)
Article
Patent abstract
The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Amy Ripka0
Christopher Fanger0
Dennis John Underwood0
Glenn R. Larsen0
Jayhong A. Chong0
Magdalene M. Moran0
Manfred Weigele0
Xiaoguang Zhen0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07998980 Compounds for modulating TRPV3 function US Patent 7998980 Compounds for modulating TRPV3 function
Infobox
Patent Number
07998980
Patent Number
7998980
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07998980 Compounds for modulating TRPV3 function
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07998980
Date of patent
August 16, 2011
Patent application number
11901253
Date Filed
September 14, 2007
Patent primary examiner
Find more entities like US Patent 7998980 Compounds for modulating TRPV3 function
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.